Live Analyst Rating Changes 1527 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Corinne Johnson
GS
Corinne Johnson
Goldman Sachs
Wall Street Analyst
★★☆☆☆
#1852
on 13Foresight · ranked by our own returns
62%
Success Rate
-2.6%
Average Return
20 of 32 calls profitable · -9.1% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 62% of Corinne Johnson's ratings turned a profit when each position was held for 1 year — averaging -2.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

45 Buy 18 Hold 8 Sell
Corinne's Stock Coverage 23 ratings · 2026-06-21
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
AMLX
Amylyx Pharmaceuticals Inc
 Jun 18, 2026 BUY Strong Buy
+46.8% avg upside
13 analysts
$23.00
46.83% Upside
 ·
RYTM
Rhythm Pharmaceuticals
 Jun 14, 2026 BUY Strong Buy
+25.2% avg upside
19 analysts
$159.00
64.34% Upside
 +6.8%
HALO
Halozyme
 Jun 14, 2026 SELL Strong Buy
-13.7% avg upside
20 analysts
$57.00
16.82% Downside
 +3.8%
TGTX
TG Therapeutics
 Jun 03, 2026 HOLD Strong Buy
-34.4% avg upside
19 analysts
$41.00
22.91% Downside
 +26.0%
IDYA
IDEAYA Biosciences
 Jun 03, 2026 HOLD Strong Buy
+55.2% avg upside
29 analysts
$36.00
15.29% Upside
 +10.1%
SNDX
Syndax Pharmaceuticals
 Jun 03, 2026 BUY Strong Buy
+88.8% avg upside
27 analysts
$34.00
79.03% Upside
 +3.8%
ORIC
Oric Pharmaceuticals
 Jun 02, 2026 BUY Strong Buy
+180.3% avg upside
19 analysts
$15.00
76.59% Upside
 +8.5%
NBIX
Neurocrine
 Jun 02, 2026 BUY Strong Buy
+7.8% avg upside
37 analysts
$213.00
34.57% Upside
 +3.2%
BHVN
Biohaven Ltd.
 May 28, 2026 BUY Strong Buy
+87.5% avg upside
25 analysts
$25.00
84.23% Upside
 +32.5%
ALT
Altimmune
 Apr 24, 2026 HOLD Strong Buy
+935.8% avg upside
19 analysts
$2.50
7.50% Downside
 +1.8%
IMVT
Immunovant
 Apr 15, 2026 HOLD Strong Buy
+8.9% avg upside
24 analysts
$32.00
9.55% Downside
 +26.5%
ROIV
Roivant Sciences
 Apr 15, 2026 BUY Strong Buy
+2.5% avg upside
17 analysts
$41.00
30.44% Upside
 +6.9%
GPCR
Structure Therapeutics, Inc. Sponsored ADR
 Mar 16, 2026 BUY Strong Buy
+132.5% avg upside
17 analysts
$101.00
126.83% Upside
 -35.4%
GERN
Geron
 Feb 25, 2026 SELL Strong Buy
+239.8% avg upside
19 analysts
$1.00
20.59% Downside
 +16.9%
CGON
CG Oncology, Inc.
 Jan 12, 2026 BUY Strong Buy
+41.1% avg upside
17 analysts
$82.00
34.25% Upside
 +13.7%
MBX
MBX Biosciences, Inc.
 Dec 04, 2025 SELL Strong Buy
+53.4% avg upside
14 analysts
$31.97
25.62% Downside
 -31.3%
AVBP
ArriVent BioPharma, Inc.
 Jul 18, 2025 BUY Strong Buy
+37.0% avg upside
15 analysts
 — +44.0%
HRMY
Harmony Biosciences Holdings
 Jul 10, 2025 HOLD Strong Buy
+39.6% avg upside
13 analysts
$33.00
0.78% Downside
 -12.3%
FULC
Fulcrum Therapeutics
 Jul 31, 2024 BUY Hold
+138.4% avg upside
13 analysts
 — -27.5%
ALEC
Alector
 Jul 24, 2024 SELL Hold
+532.1% avg upside
14 analysts
 — +71.7%
LONA
LeonaBio
 Jun 18, 2024 HOLD Buy
+13.9% avg upside
9 analysts
 — -88.1%
BTAI
Bioxcel Therapeutics
 Nov 14, 2023 HOLD Buy
+1918.5% avg upside
12 analysts
 — -87.7%
ACRS
Aclaris Therapeutics
 Aug 07, 2023 BUY Strong Buy
+122.2% avg upside
15 analysts
 — -87.0%
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Corinne Johnson — Frequently Asked Questions
How accurate are Corinne Johnson's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Corinne's ratings were profitable over a one-year hold, with an average return of -2.7% per rating, or -12.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Corinne ranked on 13Foresight?
Corinne Johnson is currently ranked #1852 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Corinne cover?
Corinne most recently has ratings on AMLX, RYTM, HALO, TGTX, IDYA, SNDX, ORIC, NBIX, BHVN, ALT, IMVT, ROIV and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.